ADIPOQ and obesity disorder: Obesity is accompanied by a chronic inflammatory state and significantly reduced circulating ADPN (Kirichenko et al., 2022; Tural et al., 2023), which exacerbates insulin resistance, inflammation, and cardiovascular disease (CVD).